Biotinylated Anti-Human CXCL16 0 BewertungenSubmit a Review Produktdetails Katalognummer: 500-P200BT Beschreibung: Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hCXCL16. Anti-Human CXCL16 specific antibody was purified by affinity chromatography and then biotinylated. Immunogen: E.coli derived Recombinant Human CXCL16 (PeproTech catalog# 300-55) Sandwich ELISA: To detect hCXCL16 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human CXCL16 (500-P200) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hCXCL16. Western Blot: To detect hCXCL16 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hCXCL16 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. Note: 1mg will be provided as 2x500μg. crossreactivity: Human References SDS Datenblattsuche Product Line Country Of Origin: USA Not for human use. Research Interest Chemotaxis Immune System Inflammation Wound Healing product.subtitle.recentcitations Erstautor Bouhaddou, M Titel The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Literaturstelle Cell; 182(3) pg685-712.e19 PubMed ID 32645325 Erstautor Blanco-Melo, D Titel Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Literaturstelle Cell; 181(5) pg1036-1045.e9 PubMed ID 32416070 Erstautor Scholz, F Titel Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. Literaturstelle The Journal of Investigative Dermatology; 127(6) pg1444-55 PubMed ID 17363916